Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (563)	3/22/2000 12:18:00 PM
From: scaram(o)uche	Read Replies (1) of 569

biz.yahoo.com Wednesday March 22, 9:13 am Eastern Time Company Press Release SOURCE: Genzyme Surgical Products Genzyme Surgical Products Receives FDA Clearance for Sepramesh(TM) CAMBRIDGE, Mass., March 22 /PRNewswire/ -- Genzyme Surgical Products (Nasdaq: GZSP - news) today announced that it has received 510(k) clearance from the FDA to market Sepramesh(TM) Biosurgical Composite for use in hernia repair procedures. Sepramesh is a prosthetic surgical mesh designed to be sutured in place along the abdominal wall to support and strengthen hernia repairs. Sepramesh offers significant advantages over traditional mesh products because it contains a bioresorbable barrier that separates the mesh from underlying tissue and organ surfaces to minimize tissue attachment to the mesh. Traditional mesh products often become a focal point for adhesions -- fibrous bands of scar tissue that form following surgery, potentially compromising hernia repairs and complicating future procedures. (snip)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next